Unjha Formulations Reaches All-Time High in Stock Price, Outperforms Sector Despite 'Hold' Call

Unjha Formulations, a microcap pharmaceutical company, has recently reached an all-time high in its stock price on November 10th, 2024. This news comes as the stock call for the company by MarketsMOJO is a 'Hold'.

The stock price for Unjha Formulations hit a new 52-week high of Rs. 39 on the same day, but underperformed the sector by -9.82%. The stock has also seen a trend reversal after two consecutive days of gains. However, it did open with a gain of 2% today and reached an intraday high of Rs. 39, showing a 5.41% increase.

On the other hand, the stock also touched an intraday low of Rs. 33.3, which is a -10% decrease. This high volatility is reflected in the stock's intraday volatility of 7.88%, calculated from the weighted average price.

Despite this, Unjha Formulations is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.

In terms of performance, Unjha Formulations has shown a significant increase of 92.15% in the past year, while the Sensex has only seen a 22.33% increase. This showcases the company's strong performance in the pharmaceutical industry.

Overall, Unjha Formulations' recent all-time high in stock price is a positive sign for the company, despite the 'Hold' call by MarketsMOJO. With its strong performance and positive trend, the company continues to be a promising player in the microcap pharmaceutical market.